Transgene Biotek Ltd, established in March 1990 by Dr. Koteswara Rao, is a pioneering biotechnology company in India. Initially focused on diagnostic kits, Transgene expanded into biotech research, notably selling its genetically engineered Hepatitis B vaccine technology to Serum Institute in 1999. The company specializes in research, development, and manufacturing of medical reagents, including chemical and immuno-diagnostic reagents for disease diagnosis. Their products reach markets in Africa, Russia, China, Malaysia, and the Philippines. Transgene is advancing with a Rs. 30 crore project to establish a new manufacturing facility at Anrich Industrial Area, supported by financial backing from Batterymarch Financial Management USA.
The company has integrated technology from RBB Inc, USA for Erythropoietin production and completed a merger with Saket Biotechnologies in 2005. It commenced Omega-3 DHA production in 2012-13 and formulated a molecule for a major pharma company for US studies in 2020-21. Transgene focuses on developing novel therapies in oncology, auto-immune diseases, and innovative drug delivery technologies.
